tldrdailynews.com logo
Tag

Trumprx

All articles tagged with #trumprx

Trump unveils Regeneron pact to lower Medicaid drug costs
politics1 month ago

Trump unveils Regeneron pact to lower Medicaid drug costs

President Trump announced a deal with Regeneron to reduce prices on all Regeneron drugs sold on Medicaid, including Praluent at $225 on the TrumpRx site, as part of a broader White House drug-pricing push. Regeneron also pledged about $27 billion in U.S. R&D/manufacturing investments. Details of the contracts remain largely undisclosed, but the administration is promoting the agreements ahead of the midterm elections as part of its effort to reshape U.S. drug pricing.

via PBS|
#drug-pricing#medicaid#politics
TrumpRx: Small Discounts, Big Questions on Real Price Relief
health2 months ago

TrumpRx: Small Discounts, Big Questions on Real Price Relief

TrumpRx.gov, launched to curb prescription costs, has offered discounts on only 54 drugs—many with cheaper generics or other savings options—and remains far from an insurance-friendly tool, with limited awareness; experts say its real impact hinges on scale, broader drug coverage, price transparency, and potential congressional action to codify MFN-style deals into law.

via NBC News|
#drug-pricing#health#health-policy
TrumpRx Promises Grand Savings, Delivers Narrow Drug List After One Month
healthcare2 months ago

TrumpRx Promises Grand Savings, Delivers Narrow Drug List After One Month

One month after its launch, TrumpRx has only a small catalog of drugs (44 listed) despite lofty promises of broad discounts, with many items already available as generics and no clear usage data released. Private deals with drugmakers remain in flux, limiting impact on prices, while administration officials trumpet progress amid bipartisan scrutiny and questions about affordability gains for most patients.

via statnews.com|
#drug-pricing#generics#healthcare
TrumpRx Debuts Amid Skepticism Over Pricing Impact
politics3 months ago

TrumpRx Debuts Amid Skepticism Over Pricing Impact

The White House launched TrumpRx (trumprx.gov) to help uninsured Americans find discounted prices for high-cost, brand-name drugs. It doesn’t sell drugs directly; users browse discounted medicines and either receive coupons at pharmacies or are redirected to manufacturers’ sites. Discounts come from voluntary 'most favored nation' deals with 16 major drugmakers, but full terms are not public. Economists say the savings are likely modest and mainly increase price transparency; the platform could help those not covered by insurance, especially for lifestyle drugs like fertility or weight-loss treatments. Democrats criticize it as a vanity project and raise concerns about potential conflicts with BlinkRx and Trump family involvement; long-term impact remains uncertain.

via latimes.com|
#blinkrx#democrats#drug-pricing
TrumpRx launches price-cut drug portal listing 43 meds for cash buyers
healthcare3 months ago

TrumpRx launches price-cut drug portal listing 43 meds for cash buyers

Trump announced TrumpRx, a new online portal that lists discounted prices for 43 commonly used drugs and directs consumers to manufacturers’ sites to complete purchases. The site does not sell meds or accept insurance; discounts apply only to cash-paying patients, with no impact on insurance deductibles. The White House says the portal offers immediate relief and plans to expand with more drugmakers, including notable discounts such as Wegovy as low as $149/month. It’s intended as a price-checking tool rather than a storefront.

via cbsnews.com|
#cashprice#discounteddrugs#drugpricing
TrumpRx Launches as Government Price-Comparison Tool for Prescriptions
technology3 months ago

TrumpRx Launches as Government Price-Comparison Tool for Prescriptions

The Trump administration unveiled TrumpRx.gov, a government site that lets users look up prescription drugs and then navigate to buy them elsewhere; it does not sell meds itself. It lists 43 drugs with prices from $3 to over $5,500 and warns that using insurance may yield lower co-pays, highlighting continued price-comparison challenges in the prescription market.

via The New York Times|
#insurance-co-pays#medicare-medicaid#prescription-pricing
politics3 months ago

TrumpRx launches discount drug portal, aims to cut costs but skeptics doubt sweeping savings

President Trump unveiled TrumpRx, a direct-to-consumer site offering discounts on about 40 branded medicines from five major drugmakers with GoodRx backing; experts say savings may be muted for many since insurance plans and deductibles often yield lower costs, and pricing details remain unclear. The administration touts it as transformative, but critics warn it could curb competition and that broader Medicare drug-price negotiations would be more effective. A potential Express Scripts agreement could expand coverage if the regulatory environment allows, signaling that Congress may need to act to count purchases toward deductibles.

via Politico|
#direct-to-consumer#drug-pricing#goodrx
TrumpRx: White House rolls out cash-pay drug hub to lower costs
politics3 months ago

TrumpRx: White House rolls out cash-pay drug hub to lower costs

The White House announced TrumpRx, a direct-to-consumer hub that directs cash-paying patients to discounts offered by drugmakers on their own sites, as part of efforts to lower U.S. prescription costs. The site does not sell drugs itself and may not benefit insured patients who rely on coverage, but could help uninsured or underinsured access drugs not widely covered, such as obesity medications; participating makers include Lilly and Novo Nordisk, with prices advertised (e.g., Ozempic and Wegovy at about $350/month) amid broader debated savings, since actual prices often depend on rebates and payer contracts. The overall impact on out-of-pocket costs remains uncertain.

via CNBC|
#direct-to-consumer#discounts#drug-pricing
healthcare4 months ago

AbbVie, U.S. Government Strike Deal to Expand Access and Invest in Domestic Pharma

AbbVie and the Trump administration announced a three-year agreement to boost U.S. access and affordability: AbbVie will offer low Medicaid prices, expand direct-to-patient access via the TrumpRx program for medicines including ALPHAGAN, COMBIGAN, HUMIRA and SYNTHROID, and commit $100 billion in U.S.-based R&D and manufacturing investments over the next decade, in exchange for tariff relief and exemption from future price mandates; the deal aims to address all four of the President's drug pricing priorities, with terms kept confidential.

via AbbVie News Center|
#abbvie#drug-pricing#healthcare
Trump secures agreements with nine drugmakers to reduce medication costs
business5 months ago

Trump secures agreements with nine drugmakers to reduce medication costs

Nine pharmaceutical companies have committed to President Trump's drug pricing policies, including lowering U.S. prices for some drugs and participating in the upcoming TrumpRx platform, as part of a broader effort to align U.S. drug prices with those in other developed countries and promote domestic manufacturing. The deals involve offering drugs at most favored nation prices, investing in domestic production, and donating ingredients to the national stockpile, though some drugs are already available as generics.

via Axios|
#business#drug-pricing#pharmaceutical-companies